Premium
The recent deal by CVC Capital Partners for HealthCare Global Enterprises Ltd (HCG) has been done at a premium to the oncology chain's current stock price but looks moderately discounted compared with others. Going by VCCircle estimates, the investment amount for a 36% stake in HCG is Rs 600-610 crore, which ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
